A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepati⦠(NCT06685692) | Clinical Trial Compass
CompletedPhase 2
A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)
United States4 participantsStarted 2024-11-04
Plain-language summary
A Phase 2 Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Subjects with Moderate Alcohol Associated Hepatitis (Part 1)
Who can participate
Age range21 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult ā„ 21 years old on the day of signing the informed consent form;
* Clinical diagnosis of alcoholic hepatitis, based on clinical features and laboratory testing, confirmed by the Investigator at screening
* Agreement to abstain from alcohol and utilize resources to cease at-risk behaviors during the trial, including addiction/alcohol abuse treatment
* Ability and willingness to swallow tablets
* Willingness to provide signed informed consent, prior to any trial-related procedures and willingness to comply with the trial procedures and requirements
Exclusion Criteria:
* Pregnant, intending to become pregnant (or father a child), or breastfeeding
* Current or recent enrollment in another interventional trial in the 30 days prior to screening